BCR::ABL1 has constitutively high tyrosine kinase activity and is considered the hallmark of CML Ph+ because it is involved in disease’s pathogenesis and progression [15]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.